World Health Organization has stated that thousands of experimental Ebola vaccine doses will be rolled out early 2015 by Western drug manufacturers.
The two experimental Vaccines which however are to be treated as “candidate” vaccines since there are not yet licensed treatment for Ebola are vaccines made by UK-based drugs giant GlaxoSmithKline (GSK), and the other by US group NewLink Genetics --have proved promising.
Speaking with AFP, the assistant director general of WHO, Marie-Paule Kieny said “If everything goes well, we may be able to begin using some of these vaccines in some of the affected countries at the very beginning of next year." And two candidate vaccines "have given very promising results in monkeys, but monkeys are not humans," she added.
800 vials of the NewLink vaccine have been donated to WHO by the Canadian government and 10,000 doses of the GSK vaccine would be available in the coming months.
Meanwhile, the WHO’s official count for the outbreak has reached over 5,800 people infected and 2,800 dead. It is also feared that the number of cases could quadruple to more than 20,000 by early November.
No comments:
Post a Comment